Moderna fell 6.2% in the premarket, after Citigroup downgraded Moderna's rating from “neutral” to “sold.”

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.